Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Browse > Organization > National Institute for Health and Clinical Excellence (NICE)

NGC Browse - Organizations

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z List all

National Institute for Health and Clinical Excellence (NICE)


Check the box next to a guideline to add it to your Guideline Collection. Then click on the "Add to Guideline Collection" button located on the page.

Guidelines 1 to 20 of 120

  Title
  (1) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (2) 2007 addendum. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2001 Jan (revised 2006 Nov; addendum released 2007 Sep). 64 pages. NGC:005956
  Abatacept for the treatment of rheumatoid arthritis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2008 Apr. 29 pages. NGC:006483
  Adalimumab for the treatment of psoriatic arthritis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Aug. 26 pages. NGC:005900
  Adalimumab, etanercept and infliximab for ankylosing spondylitis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2008 May. 47 pages. NGC:006523
  Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Feb. 37 pages. NGC:004902
  Alteplase for the treatment of acute ischaemic stroke. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jun. 22 pages. NGC:005742
  Anaemia management in chronic kidney disease. A national clinical guideline for management in adults and children. National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.]. 2006. 172 pages. NGC:005249
  Anakinra for rheumatoid arthritis. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2003 Nov. 19 pages. NGC:004809
  Atrial fibrillation. National clinical guideline for management in primary and secondary care. National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.]. 2006. 173 pages. NGC:005149
  Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 34 pages. NGC:005509
  Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2005 Jan. 51 pages. NGC:005419
  Brief interventions and referral for smoking cessation in primary care and other settings. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Mar. 36 pages. NGC:005214
  Caesarean section. National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.]. 2004 Apr. 38 pages. NGC:003544
  Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2006 Apr. 34 pages. NGC:005415
  Cardiac resynchronisation therapy for the treatment of heart failure. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 May. 28 pages. NGC:005668
  Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jun. 45 pages. NGC:005735
  Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.]. 2003 Jul. 163 pages. NGC:003549
  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. National Collaborating Centre for Chronic Conditions - National Government Agency [Non-U.S.]. 2004 Feb. 232 pages. NGC:003545
  Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.]. 2007 Jan. 28 pages. NGC:005508
  Clinical guidelines for type 2 diabetes. Prevention and management of foot problems. National Collaborating Centre for Primary Care - National Government Agency [Non-U.S.]. 2004 Jun 17. 103 pages. NGC:003546


Search Help
Detailed Search
Frequent Searches